251 related articles for article (PubMed ID: 10897331)
21. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
22. Nucleolar organizer region in transitional cell carcinoma of the bladder.
Pisac VP; Krizanac S; Andelinović S
Acta Med Croatica; 1997; 51(2):83-6. PubMed ID: 9204592
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
[TBL] [Abstract][Full Text] [Related]
24. [Application of the nucleolar organizer regions to urinary cytology and its computer-assisted image analysis].
Takeuchi T; Nagatani Y; Tada K; Sugiyama S; Koide T; Sakai S; Tanaka T; Mori H; Yamamoto N; Kobayashi S
Nihon Hinyokika Gakkai Zasshi; 1991 Sep; 82(9):1494-503. PubMed ID: 1942708
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
Zambelli S; Zanin A; Gaglio A; Zai G; Bosco E; Andrion A; Magnani C
Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
[TBL] [Abstract][Full Text] [Related]
26. [Nucleolar organizers in superficial bladder tumors. Prognostic analysis of 37 observations].
Clement T; Visseaux-Coletto B; Adnet JJ; Ploton D; Lardennois B
Prog Urol; 1991 Apr; 1(2):216-29. PubMed ID: 1844824
[TBL] [Abstract][Full Text] [Related]
27. AgNOR/P53 expression compared with different grades in bladder carcinoma.
Karakök M; Aydin A; Bakir K; Uçak R; Korkmaz C
Int Urol Nephrol; 2001; 33(2):353-5. PubMed ID: 12092655
[TBL] [Abstract][Full Text] [Related]
28. Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancer.
Sacks NP; Robertson JF; Ellis IO; Nicholson RI; Crocker J; Blamey RW
Eur J Surg Oncol; 1992 Apr; 18(2):98-102. PubMed ID: 1582518
[TBL] [Abstract][Full Text] [Related]
29. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
30. Nucleolar organizer regions in transitional cell tumors of the bladder.
Cairns P; Suarez V; Newman J; Crocker J
Arch Pathol Lab Med; 1989 Nov; 113(11):1250-2. PubMed ID: 2479357
[TBL] [Abstract][Full Text] [Related]
31. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
[TBL] [Abstract][Full Text] [Related]
32. Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma.
Pich A; Pisani P; Kzengli M; Cappello N; Navone R
Br J Cancer; 1991 Aug; 64(2):327-32. PubMed ID: 1716455
[TBL] [Abstract][Full Text] [Related]
33. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
Barzilai A; Goldberg I; Yulash M; Pavlotsky F; Zuckerman A; Trau H; Azizi E; Kopolovic J
Am J Dermatopathol; 1998 Oct; 20(5):473-7. PubMed ID: 9790108
[TBL] [Abstract][Full Text] [Related]
34. Nucleolar organiser regions as a marker of growth rate in squamous cell carcinoma of the lung.
Abe S; Sukoh N; Ogura S; Kunikane H; Watanabe N; Nakajima I; Takekawa H; Kawakami Y
Thorax; 1992 Oct; 47(10):778-80. PubMed ID: 1481176
[TBL] [Abstract][Full Text] [Related]
35. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
Tomobe M; Shimazui T; Uchida K; Akaza H
Anal Cell Pathol; 2001; 22(4):193-9. PubMed ID: 11564895
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of argyrophil nucleolar organiser regions (AgNORs) in colorectal cancer.
Rayter Z; Surtees P; Tildsley G; Corbishley C
Eur J Surg Oncol; 1992 Feb; 18(1):37-40. PubMed ID: 1737591
[TBL] [Abstract][Full Text] [Related]
37. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
[TBL] [Abstract][Full Text] [Related]
38. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
39. Interphase nucleolar organiser regions and survival in squamous cell carcinoma of the bronchus: a 10 year follow up study of 138 cases.
Boldy DA; Ayres JG; Crocker J; Waterhouse JA; Gilthorpe M
Thorax; 1991 Dec; 46(12):871-7. PubMed ID: 1792632
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas.
Yue L; Iwai M; Furuta I
Oral Oncol; 1999 Jan; 35(1):70-6. PubMed ID: 10211313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
